151 related articles for article (PubMed ID: 426316)
1. Plasminogen and moderate doses of urokinase in the treatment of acute pulmonary embolism.
Griguer P; Charbonnier B; Latour F; Fauchier JP; Brochier M
Angiology; 1979 Jan; 30(1):1-12. PubMed ID: 426316
[No Abstract] [Full Text] [Related]
2. Modifications in coagulation parameters induced by treatment associating urokinase (2000 u CTA/kg/h) with heparin.
Juhan I; Calas MF; Buonocore M; Mathieu P; Isnard G; Cazenave B; Serradimigni A
Thromb Haemost; 1979 Oct; 42(3):945-54. PubMed ID: 315625
[No Abstract] [Full Text] [Related]
3. [Treatment of acute pulmonary embolism with urokinase compared with the combination plasminogen-urokinase. Apropos of 67 cases].
François G; Charbonnier B; Raynaud P; Garnier LF; Griguer P; Brochier M
Arch Mal Coeur Vaiss; 1986 Apr; 79(4):435-42. PubMed ID: 3090961
[TBL] [Abstract][Full Text] [Related]
4. Does thrombolytic therapy have a place in the treatment of pulmonary embolism after the acute stage?
Brochier M; Griguer P; Raynaud P; Charbonnier B; Desveaux B; François G
Haemostasis; 1986; 16 Suppl 3():58-64. PubMed ID: 3770545
[No Abstract] [Full Text] [Related]
5. [Value of Lysyl-plasminogen-urokinase sequential treatment in thrombolytic therapy].
Brochier M; Planiol T; Griguer P; Raynaud P; Fauchier JP; Charbonnier B; Latour F; Pellois A
Coeur Med Interne; 1977; 16(4):513-21. PubMed ID: 589966
[No Abstract] [Full Text] [Related]
6. [Thrombolytic agents and acute pulmonary emboli. Study of 28 cases treated by streptokinase or urokinase-heparin].
Chiche P; Bénaim R; Samama M; Maury J
Coeur Med Interne; 1978; 17(1):59-66. PubMed ID: 639489
[No Abstract] [Full Text] [Related]
7. [Inefficiency of high doses of urokinase in a massive pulmonary embolism. Possible role of an oral contraceptive].
Grand A; Drouin B; Ferry M; Heulin T; Murger JF
Nouv Presse Med; 1978 Jul 1-8; 7(27):2391. PubMed ID: 673811
[No Abstract] [Full Text] [Related]
8. [Injections of urokinase into the pulmonary artery for the treatment of acute pulmonary embolism--evaluation of 3 cases].
Takahashi T; Ozasa K; Shibata T; Tanimura C; Uyama M; Nakagawa H; Inui T; Mineo T; Miyao K
Kokyu To Junkan; 1983 Apr; 31(4):451-6. PubMed ID: 6346443
[No Abstract] [Full Text] [Related]
9. Urokinase in thromboembolic disease: Pulmonary embolism.
Sasahara AA; Stengle JM; Sherry S
Am Heart J; 1975 Mar; 89(3):403-4. PubMed ID: 1090139
[No Abstract] [Full Text] [Related]
10. [Increased fibrinolytic activity by sequential treatment with defibrase-plasminogen-urokinase in pulmonary embolism and deep venous thrombosis].
Brochier M; Griguer P; Raynaud P; Fauchier JP; Charbonnier B
Arch Mal Coeur Vaiss; 1981 Jul; 74(7):761-9. PubMed ID: 6794497
[No Abstract] [Full Text] [Related]
11. Role of dextran sulfate in urokinase therapy and evaluation of the effects by estimation of plasmin inhibitor, fibrinogenolytic degradation products, and fibrinolytic degradation products.
Hasegawa H; Nagata H; Yamauchi M; Murakoshi T; Oguma Y; Takei H; Seya T; Murao M
Jpn Heart J; 1982 May; 23(3):339-47. PubMed ID: 6178853
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of acute pulmonary emboli with urokinase in high doses. Apropos of 20 cases].
Page A; Conri C; Blanc A; Lorient MF; Boisseau M; Besse P
Coeur Med Interne; 1979; 18(2):293-300. PubMed ID: 487718
[No Abstract] [Full Text] [Related]
13. Streptokinase and urokinase in the treatment of pulmonary thromboemboli; from a national cooperative study.
Bell WR
Thromb Haemost; 1976 Feb; 35(1):57-69. PubMed ID: 785689
[TBL] [Abstract][Full Text] [Related]
14. Impaired resolution of massive pulmonary embolism associated with an inhibited fibrinolytic response.
Deitcher SR; Lucore CL; Eisenberg PR
Am J Med; 1994 May; 96(5):483-4. PubMed ID: 8192182
[No Abstract] [Full Text] [Related]
15. Changes in the plasma fibrinolytic system during urokinase therapy: comparison of tissue culture urokinase with urinary source urokinase in patients with pulmonary embolism.
Marder VJ; Donahoe JF; Bell WR; Cranley JJ; Kwaan HC; Sashara AA; Barlow GH
J Lab Clin Med; 1978 Nov; 92(5):721-9. PubMed ID: 712206
[No Abstract] [Full Text] [Related]
16. Evolution of plasma specific fibrin degradation products during thrombolytic therapy in patients with thrombo-embolism.
Faivre R; Mirshahi M; Ducellier D; Soria C; Soria J; Mirshahi M; Kieffer Y; Bassand JP; Caen J; Maurat JP
Thromb Res; 1988 May; 50(4):583-9. PubMed ID: 3413720
[No Abstract] [Full Text] [Related]
17. [Fibrinolytic therapy of deep venous thrombosis. Streptokinase, urokinase, plasminogen substitution].
Theiss W; Kriessmann A; Wirtzfeld A
Dtsch Med Wochenschr; 1980 Feb; 105(8):243-6. PubMed ID: 6986252
[No Abstract] [Full Text] [Related]
18. Oral administration of urokinase.
Sumi H; Sasaki K; Toki N; Robbins KC
Thromb Res; 1980 Dec 1-15; 20(5-6):711-4. PubMed ID: 7015555
[No Abstract] [Full Text] [Related]
19. Thrombolytic therapy of pulmonary thromboembolism.
Genton E
Prog Cardiovasc Dis; 1979; 21(5):333-41. PubMed ID: 419322
[No Abstract] [Full Text] [Related]
20. Local fibrinolytic therapy in acute pulmonary embolism.
Berger T; Schäfer H; Van Gemmeren D; Heitz J; Arntz R; Sörensen R
Ann Radiol (Paris); 1987; 30(2):151-5. PubMed ID: 3619335
[No Abstract] [Full Text] [Related]
[Next] [New Search]
